Gene Therapy for Blindness Appears Initially Effective, Says US FDA – Scientific American
Scientific American |
Gene Therapy for Blindness Appears Initially Effective, Says US FDA
Scientific American (Reuters) – Spark Therapeutics Inc's experimental gene therapy for a rare inherited form of blindness is effective, though it is unclear whether the benefit lasts over time, according to a preliminary review by the U.S. Food and Drug Administration … Seeing hope: FDA panel considers gene therapy for blindness The FDA could soon approve gene therapy for blindness With AdComm meeting looming, FDA shares concerns about Spark's lead gene therapy |
